Clinical Trials Sponsored by Resmed Inc

Total 36164 results

Keymed Biosciences Co.Ltd

Recruiting

The Study of CM326 in Adult Subjects With Atopic Dermatitis

Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Not yet recruiting

A Study of CM310 in Subjects With Chronic Pruritus

Chronic Pruritus of Unknown Origin
Keymed Biosciences Co.Ltd

Not yet recruiting

A Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （CROWNS-2）

Chronic Rhinosinusitis With Nasal Polyposis
Keymed Biosciences Co.Ltd

Recruiting

Single Ascending Dose Study of CM338 in Healthy Volunteers

Healthy

China
Keymed Biosciences Co.Ltd

Recruiting

The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps

China
Keymed Biosciences Co.Ltd

Completed

Single Ascending Dose Study of CM326 in Healthy Volunteers

Asthma

China
Yale University
DreaMed

Withdrawn

Real World Evaluation of Advisor Pro in Clinical Practice

Type1diabetes
Avinashilingam Deemed University

Completed

Health Status of Workers in Photocopier Units

Exposure to Photocopiers on a Professional Basis

India
Keymed Biosciences Co.Ltd

Not yet recruiting

Study of CM313 in Healthy Subjects

Healthy
Keymed Biosciences Co.Ltd

Not yet recruiting

Study Evaluating the Pharmacokinetics of CM310 in Healthy Subjects

Healthy

China
Keymed Biosciences Co.Ltd

Recruiting

The Study of CM326 in Moderate-to-severe Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Not yet recruiting

A Study of CM313 Injection in Subjects With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Keymed Biosciences Co.Ltd

Not yet recruiting

Multiple Ascending Dose Study of CM338 in Healthy Volunteers

Healthy Subjects
Keymed Biosciences Co.Ltd

Not yet recruiting

A Study of CM336 in Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma
Keymed Biosciences Co.Ltd

Recruiting

A Study of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Recruiting

A Study of CM350 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Keymed Biosciences Co.Ltd

Recruiting

The Study of CM310 in Patients With Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Recruiting

Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and Lymphoma

Lymphoma | Multiple Myeloma

China
Keymed Biosciences Co.Ltd

Active, not recruiting

A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps (DUBHE)

Chronic Rhinosinusitis With Nasal Polyps

China
Keymed Biosciences Co.Ltd

Completed

Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

Moderate-to-severe Atopic Dermatitis

China
Association REMEDE
Pfizer

Completed

Efficacy Study of Recombinant Growth Hormone on Muscle Function in Children Long-term Treated With Glucocorticoid

Chronic Disease | Growth Retardation | Glucocorticoid Therapy, Response to

France
ResMed
The University of Western Australia; Sir Charles Gairdner Hospital

Terminated

Juno Perth Clinical Trial

Respiratory Insufficiency | Chronic Obstructive Pulmonary Disease (COPD) | Obesity Hypoventilation Syndrome | Neuromuscular Disease | Upper Airway Obstruction

Australia
ResMed
Imperial College London; Royal Brompton & Harefield NHS Foundation Trust

Completed

Mechanisms of Action of Adaptive Servoventilation

Heart Failure | Sleep Apnea Syndromes

United Kingdom
Keymed Biosciences Co.Ltd

Not yet recruiting

Study of CM310 in Subjects With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

China
Keymed Biosciences Co.Ltd

Not yet recruiting

A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis
Keymed Biosciences Co.Ltd

Recruiting

Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy

IgA Nephropathy

China
Keymed Biosciences Co.Ltd

Recruiting

Study to Evaluate Pharmacokinetics, Safety and Efficacy of CM310

Healthy

China
Keymed Biosciences Co.Ltd

Recruiting

A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatis

Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Recruiting

The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Recruiting

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901

Gastric Cancer | Pancreatic Cancer | Advanced Solid Tumor | Gastroesophageal Junction Adenocarcinoma

China
Keymed Biosciences Co.Ltd

Completed

A Study of CM310 in Subjects With Moderate to Severe Asthma

Asthma

China
Keymed Biosciences Co.Ltd

Active, not recruiting

Study of CM310 in Subjects With Allergic Rhinitis (PHECDA)

Allergic Rhinitis

China
Keymed Biosciences Co.Ltd

Completed

Study of CM310 in Healthy Subjects

Healthy

China
Keymed Biosciences Co.Ltd

Completed

A Multiple Ascending Doses Study of CM326 Injection in Healthy Subjects

Asthma

China
BioSCIENCE GmbH
HeiMed

Completed

Safety and Efficacy of the HA-based Dermal Fillers HYAPROF® SOFT and HYAPROF® BALANCE (PMCF_HYAPROF)

Dermal Filler

Germany
BioSCIENCE GmbH
HeiMed

Completed

Safety and Efficacy of the HA-based Dermal Fillers HYAcorp Lips and Face (PMCF_HYAcorp)

Dermal Filler

Germany
Keymed Biosciences Co.Ltd

Completed

Subcutaneously CM310/Placebo in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CROWNS-1)

Chronic Rhinosinusitis (Diagnosis) | Nasal Polyps

China
Keymed Biosciences Co.Ltd

Completed

Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

Moderate-to-severe Atopic Dermatitis

China
Neomed Institute
Covance

Completed

NEO6860, a TRPV1 Antagonist, First in Human Study

Osteoarthritis, Knee

United Kingdom
GLSMED Learning Health S.A.

Recruiting

IntelligentCare: Wearable-based Intervention (ICare)

Sleep | Exercise | Multimorbidity

Portugal
Rabin Medical Center
DreaMed

Withdrawn

The Advisor Pro Direct Study

Type 1 Diabetes Mellitus

Israel
Matias Vested

Completed

Intubating Conditions During Rapid Sequence Induction in Elderly With Either Suxamethonium 1.0 mg/kg or Rocuronium 1.0 mg/kg

Intubation Conditions

Denmark
BrosMed Medical Co., Ltd

Completed

Efficacy and Safety of Intravascular High-pressure Cutting Balloon Catheters for PCI

Patients With Atherosclerotic Plaques in the Coronary Arteries That Require Excision

China
BrosMed Medical Co., Ltd

Completed

Wedge NC - Scoring Balloon Dilatation Catheter

Coronary Artery Disease

China
Thomas Jefferson University
Heart and Diabetes Center North Rhine-Westphalia; Inova Fairfax Hospital; Resmed... and other collaborators

Terminated

Patients With Heart Failure With Preserved Ejection Fraction Adherence to ASV Therapy (PEP ASV) (PEP-ASV)

Heart Failure | Sleep Disorder; Breathing-Related

United States, Germany
BrosMed Medical Co., Ltd

Completed

Evaluate Safety and Efficacy of Pronavi Microcatheter for Use in Endovascular Interventions

Coronary Artery Disease | Peripheral Arterial Disease

China
BrosMed Medical Co., Ltd

Completed

Evaluate Safety and Efficacy of Alveo HP Balloon Dilatation Catheter for Balloon Dilatation of Coronary Artery Stenosis

Coronary Artery Disease

China
Matias Vested

Completed

Mivacurium 0.2 mg/kg in Young (18 - 40 Years) and Elderly (= 80 Years) Patients

Onset Time of Mivacurium, Duration of Action of Mivacurium

Denmark
Matias Vested

Completed

An Observational Study of Cisatracurium 0.15 mg/kg in Young and Elderly (≥ 80 Years) Patients.

Intubation Conditions | Onset Time of Cisatracurium | Duration of Action of Cisatracurium

Denmark
University Hospital, Grenoble
ResMed; Société francophone de pneumologie de langue francaise

Completed

Effect of Sleep Apnea Treatment on Type 1 Diabetes (DIADEME)

Type 1 Diabetes | Sleep Apnea Syndrome

France

Clinical Trials Sponsored by Resmed Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations